Coronaphobia in Rheumatic Diseases

Status Recruiting

Clinical Trial Summary

COVID-19 is a contagious respiratory disease that is caused Severe Acute Respiratory Syndrome causing Coronavirus-2 (SARS-CoV-2). The most common symptoms are fever, cough and dyspnoea. Patients with rheumatic diseases are at higher risk of infections because of disease activity and immunosuppression. In addition, old age and having concomitant chronic disease are among risk factors for coronavirus. Therefore, national health services recommend patients to practice self-isolation and self-quarantine.

Clinical Trial Description

COVID-19 is a contagious respiratory disease that is caused Severe Acute Respiratory Syndrome causing Coronavirus-2 (SARS-CoV-2). It was firstly seen in December 2019 in Wuhan, China and spread rapidly all over the world. World Health Organization (WHO) was declared COVID-19 as a pandemic in March 2020. The most common symptoms are fever, cough and dyspnoea. Social isolation and staying home have been suggested to reduce the spreading rate of COVID-19 pandemic in many countries. In addition, curfew except necessity was applied in some countries and time of curfew varied by country. Therefore, pandemic caused changes in routine life for millions of people. Patients with rheumatic diseases are at higher risk of infections because of disease activity and immunosuppression. In addition, old age and having concomitant chronic disease are among risk factors for coronavirus. Therefore, national health services recommend patients to practice self-isolation and self-quarantine. However, social isolation was concluded with more increased physical inactivity and sedentary lifestyle. The aim of this study is to investigate coronaphobia in rheumatic diseases and compare with healthy people. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05554029
Study type	Interventional
Source	Gazi University
Contact	Songul B Yentur
Phone	+90 424 2370000
Email	songulbaglan23@hotmail.com
Status	Recruiting
Phase	N/A
Start date	September 25, 2022
Completion date	December 20, 2022

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT04976972` - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation	N/A
Completed	`NCT04042792` - Characterization of Adalimumab Concentrations in Pediatric Patients With Inflammatory Rheumatic Disease With and Without Methotrexate
Completed	`NCT02944448` - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee	Phase 2
Completed	`NCT02694796` - Impact of Web and Smartphone-based Physical Activity Program on Physical Activity Level 12 Months After a Balneotherapy	N/A
Completed	`NCT02256098` - RSA RCT: ATTUNE™ TKA Versus PFC Sigma TKA	N/A
Completed	`NCT02269254` - Persona Versus NexGen	N/A
Completed	`NCT00642837` - A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets	Phase 4
Active, not recruiting	`NCT04704544` - Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE)	N/A
Completed	`NCT05026853` - Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice	N/A
Active, not recruiting	`NCT04631965` - Healthcare Transition of Adolescents With Chronic Health Conditions
Recruiting	`NCT00024479` - Natural History of Rheumatic Diseases in Minority Communities
Completed	`NCT05031104` - Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis	N/A
Not yet recruiting	`NCT04567576` - Predictive Factors for COVID-19 in Rheumatology
Completed	`NCT02291471` - Tolerance and Pharmacokinetics of T0001 in Healthy Adult Chinese Volunteers	Phase 1
Completed	`NCT01227694` - Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis	Phase 1/Phase 2
Recruiting	`NCT01071447` - Nurse-led Clinic for Patients With Rheumatic Diseases and Biological Treatment	N/A
Active, not recruiting	`NCT05618782` - Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee	Phase 2
Active, not recruiting	`NCT05543642` - The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)	Phase 4
Active, not recruiting	`NCT02694185` - Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications	N/A
Completed	`NCT04685434` - Validity and Reliability of "Shriners Hospital Upper Extremity Evaluation" in Children With Rheumatic Disease